Belinda Beresford
Belinda Beresford is an award-winning journalist and the former health and deputy news editor of the Mail & Guardian. She now lives in the United States.
No image available
/ 2 April 2007

Breast only is best

Babies of HIV-positive mothers are twice as likely to become infected by the virus if they are given formula milk in addition to breast milk, and the risk rises eleven-fold if they are given solid foods, South African researchers have found. Exactly why mixing breastfeeding with other foods increases the risk of HIV infection is still unknown.

No image available
/ 23 March 2007

TB is levelling off, says WHO

The World Health Organisation (WHO) said recently that the global tuberculosis epidemic may be leveling off, but this optimism is undermined by the reality of incomplete detection of the disease, high levels of mortality and poor information about the extent of drug resistant forms of the disease.

No image available
/ 5 March 2007

Rubbed the wrong way

A hand bobbing up and down on an erection is one of the funniest things in the world — at least when said penis is being woggled on a leafy Johannesburg street at noon on Valentine’s Day. Instantly it reminded me of my dog having a good scratch, especially as what I could see of the man’s face around his sunglasses had the same fixed look as my Alsatian when he’s trying to reach the itchy bit behind his ears.

No image available
/ 22 February 2007

A red cross for budget

Finance Minister Trevor Manuel highlighted under-capacity in the struggling healthcare system in this week’s budget. His department is expecting the number of people who will receive HIV/Aids treatment through the state system merely to double in the next three years.

No image available
/ 9 February 2007

‘It’s another armament’

At 11.22am, as the needle drew back from 19-year-old Thabo’s arm in a room in Soweto, applause rang out. South Africa’s largest anti-HIV vaccine trial had begun. Researchers hope the MRKAd5 multivalent HIV vaccine will prevent at least 30% of new infections, and may slow the progression of HIV to Aids.

No image available
/ 9 February 2007

Chemical condom trial canned

It took just 35 laboratory tests to bring more than seven years and millions of dollars of research to a shocking halt last week — and to dampen the hopes of protecting millions of women against HIV infection. The Ushercell microbicide trial was stopped prematurely after the independent safety oversight committee discovered that more women using the anti-HIV gel.

No image available
/ 2 February 2007

MCC stalls new Aids drugs

South Africans have been denied the “biggest advance” in antiretroviral therapy over the last few years because of a lack of urgency in the drug registration process in South Africa, according to the Treatment Action Campaign. The TAC is calling for the urgent registration of Tenofovir, which is considered one of the safest antiretro-viral (ARV) drugs and needs only to be taken once a day.

No image available
/ 15 January 2007

Humanity’s formidable enemy

Mycobacterium tuberculosis is the “mother of all pathogens”, able to create all its essential nutrients, eat its own cell wall without dying, and hide within the cells sent to kill it for decades. Under various names, including the “white plague” and consumption, TB has been around for thousands of years, with Egyptian mummies showing traces of it.

No image available
/ 9 January 2007

Aids, the great unknown

Prediction is very difficult, especially of the future, said Nobel Prize-winning physicist Niels Bohr. His quote is particularly appropriate looking at the future impact of HIV/Aids in South Africa because the country faces a situation as yet unknown in human history.